Takeda Pharmaceutical Company Limited (NYSE:TAK) Sees Significant Drop in Short Interest

Takeda Pharmaceutical Company Limited (NYSE:TAK) was the target of a large drop in short interest in October. As of October 31st, there was short interest totalling 6,030,000 shares, a drop of 17.4% from the October 15th total of 7,300,000 shares. Based on an average daily volume of 1,650,000 shares, the days-to-cover ratio is presently 3.7 days.

Takeda Pharmaceutical Trading Up 0.4 %

Shares of NYSE TAK opened at $13.62 on Friday. The firm’s 50 day moving average price is $14.24 and its 200-day moving average price is $13.83. Takeda Pharmaceutical has a 52-week low of $12.57 and a 52-week high of $15.08. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28. The company has a market cap of $43.34 billion, a PE ratio of 23.48, a P/E/G ratio of 0.26 and a beta of 0.54.

Hedge Funds Weigh In On Takeda Pharmaceutical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TAK. Blair William & Co. IL increased its holdings in shares of Takeda Pharmaceutical by 6.5% in the 1st quarter. Blair William & Co. IL now owns 12,649 shares of the company’s stock worth $176,000 after purchasing an additional 777 shares in the last quarter. Dorsey & Whitney Trust CO LLC raised its position in Takeda Pharmaceutical by 4.6% in the 1st quarter. Dorsey & Whitney Trust CO LLC now owns 18,197 shares of the company’s stock worth $253,000 after buying an additional 798 shares during the last quarter. SG Americas Securities LLC lifted its stake in Takeda Pharmaceutical by 5.4% during the 1st quarter. SG Americas Securities LLC now owns 16,099 shares of the company’s stock valued at $224,000 after acquiring an additional 824 shares during the period. Catalytic Wealth RIA LLC boosted its holdings in shares of Takeda Pharmaceutical by 4.0% during the 2nd quarter. Catalytic Wealth RIA LLC now owns 21,703 shares of the company’s stock valued at $281,000 after acquiring an additional 841 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Takeda Pharmaceutical by 38.6% in the second quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock worth $43,000 after acquiring an additional 859 shares during the period. 9.17% of the stock is owned by institutional investors.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.